The Rupee appreciated 18 paise to 74.73 against the U.S. Dollar in opening trade on Tuesday tracking positive domestic equities and hopes of COVID-19 vaccine.
At the interbank forex market, the domestic unit opened at 74.79 against U.S. Dollar, then gained further ground and and touched 74.73 against the US dollar, up 18 paise over its previous close. It had settled at 74.91 against the U.S. Dollar on Monday.
Forex traders said positive opening in domestic equities, foreign fund inflows and hopes of COVID-19 vaccine supported the Rupee.
A coronavirus vaccine created by the University of Oxford appears safe and induces a strong immune response within the body, scientists announced on Monday after the first phase of human trials. Also, AIIMS-Delhi on Monday began recruiting volunteers for conducting human clinical trials of the indigenously developed COVID-19 vaccine candidate Covaxin.
Meanwhile, the dollar index, which gauges the greenback’s strength against a basket of six currencies, rose 0.04% to 95.87.
On the domestic equity market front, the 30-share BSE benchmark Sensex was trading 387.14 points higher at 37,806.13 and broader NSE Nifty rose 110.25 points to 11,132.45.
Foreign institutional investors were net buyers in the capital market as they purchased shares worth ₹1,709.97 crore on Monday, according to provisional exchange data.
Brent crude futures, the global oil benchmark, rose 0.14% to $43.34 per barrel.
You have reached your limit for free articles this month.
To get full access, please subscribe.
Already have an account ? Sign in
Show Less Plan
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Faster pages
Move smoothly between articles as our pages load instantly.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Personalised recommendations
A select list of articles that match your interests and tastes.
Briefing
We brief you on the latest and most important developments, three times a day.
*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
